Zeiss VISULAS YAG III, User Manual

Page: 14 / 126

Country-specific information and labels
000000-1272-175-GA-GB-060613
8
Indication for use
The VISULAS YAG III is designed for ophthalmologic use including posterior
capsulotomy and peripheral iridotomy.

Note for VISULAS YAG III Combi:
The VISULAS YAG III Combi instrument system consists of the
VISULAS 532s laser system, the VISULAS YAG III laser system and
the LSL YAG III Combi laser slit lamp as a general applicator for the
two laser systems.
For correct operation of the VISULAS 532s, the VISULAS 532s user
manual must be observed.

Note for VISULAS Trion Combi:
The VISULAS Trion Combi instrument system consists of the
VISULAS Trion laser system, the VISULAS YAG III laser system and
the LSL Trion Combi laser slit lamp as a common applicator for the
two laser systems.
For correct operation of the VISULAS Trion, the VISULAS Trion user
manual must be observed.
The user is liable for any use of the device other than intended.
Side effects/contraindications
The VISULAS YAG III should not be used in cases of retinal detachment or
cystoid macular edema, or with patients with intraocular glass lenses. Glass
lenses can be destroyed by the effect of the optical breakdown.
The following complications have been reported after Nd:YAG laser
treatment:
* Christian Ohrloff "Die Bedeutung der intakten Hinterkapsel für den Glaskörper"
Klin. Monatsbl. Augenheilkd. 1994; 205:181-186 © 1994 F. Enke Verlag Stuttgart
The frequency and severity of complications depends on the energy applied.
The lower the energy used, the lower the degree of postoperative
inflammation and increase in intraocular pressure.
Complication Incidence
Cystoid macular edema Estimated: < 1 %
Retinal detachment* Total population: 1.4 %
After capsulotomy: 2.8 %
Endophthalmitis Estimated: < 1 %
Increased intraocular pressure Estimated: < 1 %
Rubeosis iridis (associated with
diabetes) Estimated: < 1 %